Company News

Thermo Fisher Scientific (NYSE: TMO) has signed an agreement under which Thermo Fisher will acquire Life Technologies for $76 in cash per fully diluted common share, or approximately $13.6 billion, plus $2.2 billion of net debt.

Thermo Fisher Scientific (NYSE:TMO) has signed an agreement under which Thermo Fisher will acquire Life Technologies  (NASDAQ:LIFE), for $76 in cash per fully diluted common share, or approximately $13.6 billion, plus $2.2 billion of net debt.

As quoted in the press release:

The transaction, which was approved by both companies’ boards of directors, will create an unrivaled leader in serving research, specialty diagnostics and applied markets. The combination builds on both companies’ technological strengths to accelerate results for life sciences customers working in proteomics, genomics and cell biology.

Click here to read the full Thermo Fisher Scientific (NYSE:TMO) press release

MARKETS

Markets
TSX19254.56+281.88
TSXV619.76+14.48
DOW32197.59+436.05
S&P 5004023.61+102.56
NASD12032.42+469.85
ASX6823.20+15.90

COMMODITIES

Commodities
Gold1739.60+0.96
Silver19.26+0.11
Copper3.48+0.05
Palladium2046.00+25.00
Platinum893.50+5.50
Oil98.70+1.44
Heating Oil3.66+0.02
Natural Gas8.63+0.08

DOWNLOAD FREE REPORTS

×